Sellas Life Sciences is trading at $12.01, up 4.34%, amid broad market strength.
- Broader markets are higher, with the Nasdaq up 0.94%; this may be supporting risk appetite, though no direct link to the stock’s gain was reported.
- No company-specific announcement dated September 30 appeared in search results. The latest company news found was September 25, about preclinical SLS009 data.